HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Buy rating and announces Price Target of $17.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
70 Biggest Movers From Friday
Gainers
GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.
48 Stocks Moving In Friday’s Mid-Day Session
Gainers
Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS.
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday.
